Media release Pacific Friends of Global Health calls on the Australian Government to get strongly behind a new strategy launched today by Gavi, the Vaccine Alliance, that outlines its ambitious goal to immunise at least 500 million children between 2026 and 2030, saving more than 8 million lives. Pacific Friends of Global Health said achieving […]
Thursday, December 2, 2021 Australia’s leading epidemiologists, global health, business, development and aid organisations have united to call on the Federal Government to urgently ramp up its global vaccination efforts following the emergence of the Omicron variant. The coalition, brought together by End COVID For All, includes the Business Council of Australia, the Australian Global […]
9 November 2021: The Australian Global Health Alliance is pleased to announce Medicines for Malaria Venture (MMV) as a new Bronze Sponsor. Medicines for Malaria Venture (MMV) is a leading product development partnership (PDP) in the field of antimalarial drug research and development. Its mission is to reduce the burden of malaria in disease-endemic countries by […]
The Australian Government is being urged to commit to further action to fight the COVID-19 pandemic in poor countries before the virus mutates and renders current vaccines ineffective. A new report, A Shot of Hope – Australia’s role in vaccinating the World, which the Australian Global Health Alliance co-authored, notes that two-thirds of 77 epidemiologists surveyed […]
06 October 2021 WHO recommendation for wider use of the RTS,S malaria vaccine is largely based on data gathered during malaria vaccine pilots which took place in Kenya, Ghana and Malawi Gavi, the Vaccine Alliance, the Global Fund to Fight AIDS, Tuberculosis and Malaria and global health agency Unitaid have together committed nearly US$ 70 […]
A REGIONAL COVID RESPONSE NEEDS MORE FROM AUSTRALIA Media Release | 23 September 2021 Pacific Friends of Global Health welcomes the news that the Australian Government has pledged an additional 40 million COVID-19 vaccines for the Indo-Pacific region. Australia has now promised a total of 60 million vaccines by the end of 2022. The announcement […]
GENEVA – The COVID-19 pandemic had a devastating impact on the fight against HIV, TB and malaria in 2020, according to a new report released by the Global Fund today. The Results Report shows that while some progress was made, key programmatic results have declined for the first time in the history of the Global Fund. “To mark […]
Unitaid has invested more than US$ 45 million into hepatitis C since 2015, driving the development of better and more affordable tools and demonstrating that it is possible to reach – and cure – people in resource-limited settings. “We set out to improve hepatitis C care through a complementary set of investments. Over the past […]
Unitaid and the Clinton Health Access Initiative, Inc. (CHAI) announce pricing agreement with pharmaceutical company Hetero Labs LTD to make available generic version of best-in-class second-line therapy for people living with HIV Geneva, 26 July 2021 – Unitaid and CHAI today announced a groundbreaking pricing agreement with pharmaceutical company Hetero Labs LTD to make darunavir boosted […]
New mechanism builds on Gavi COVAX Advance Market Commitment (AMC) cost-sharing arrangement Washington DC / Geneva, 26 July 2021 – COVAX and the World Bank will accelerate COVID-19 vaccine supply for developing countries through a new financing mechanism that builds on Gavi’s newly designed AMC cost-sharing arrangement. This allows AMC countries to purchase doses beyond the […]
Technology transfer agreements signed to enable expanded production of high-quality antigen rapid tests in Africa and Latin America Agreements signed with DCN Dx to transfer know-how to WAMA Diagnóstica (Brazil), and Bionote and Mologic to transfer know-how to DIATROPIX of the Institut Pasteur de Dakar (Senegal) Separate partnership between Viatris (South Africa) and Guangzhou Wondfo Biotech […]
GENEVA – The Global Fund to Fight AIDS, Tuberculosis and Malaria praised the decision by the Swiss Federal Council to make available CHF300 million to the Access to COVID-19 Tools (ACT) Accelerator – a ground-breaking global collaboration of leading public health agencies to accelerate the development, production, and equitable access to COVID-19 tests, treatments, and vaccines, […]
The Partnership for Vivax Elimination (PAVE) will support endemic countries in achieving their Plasmodium vivax (P. vivax) malaria elimination goals. PAVE will advance the development of quality-assured, child-friendly treatments for relapse prevention, and generate and consolidate evidence to support malaria-endemic countries in developing and implementing new strategies to eliminate P. vivax malaria. Geneva/Seattle, 14 July 2021 – The new Partnership […]
The signed advance purchase agreements will make doses available to COVAX starting from July to help address immediate and critical gaps in supply Addition of the Sinopharm and Sinovac vaccines, which have already been granted WHO Emergency Use Listing (EUL), further diversifies the Gavi-managed COVAX Facility portfolio, which now includes 11 vaccines and vaccine candidates […]
